A critical question for cancer therapy: what new targets exist?

Designing molecular targeted therapy with high specificity based on novel tumor biomarkers is a high priority in lung cancer research. Several molecular aberrations have been already identified in non-small cell lung cancer (NSCLC), with subsequent development of drugs targeted to these aberrations....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transl Lung Cancer Res
Glavni autori: Rosell, Rafael, Karachaliou, Niki, Codony, Jordi, Teixido, Cristina, Garcia-Roman, Silvia, Morales, Daniela, Cao, María González, Viteri, Santiago, Veliz, Ignacio, Loo, Yong, Castillo, Omar
Format: Artigo
Jezik:Inglês
Izdano: Pioneer Bioscience Publishing Company 2014
Teme:
Editorial
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367674/
https://ncbi.nlm.nih.gov/pubmed/25806328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.08.10
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items